INVO Bioscience, Inc. (INVO)

INVO Bioscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	3.02	0.82	4.16	1.04	1.48
Revenue Growth (YoY)	267.38%	-80.24%	301.06%	-29.92%	199.41%
Cost of Revenue	1.93	0.85	0.15	0.09	0.14
Gross Profit	1.09	-0.03	4.02	0.95	1.34
Selling, General & Admin	7.49	9.98	9.02	6.07	3.13
Research & Development	0.17	0.54	0.22	0.4	0
Other Operating Expenses	0.2	0.08	0	0	0
Operating Expenses	7.85	10.6	9.23	6.46	3.13
Operating Income	-6.77	-10.63	-5.22	-5.51	-1.79
Interest Expense / Income	0.93	0.06	1.27	2.84	0.39
Other Expense / Income	0.31	0.2	0.17	-0	-0.01
Pretax Income	-8.01	-10.89	-6.65	-8.35	-2.17
Income Tax	0.03	0	0	0	0
Net Income	-8.03	-10.89	-6.65	-8.35	-2.17
Shares Outstanding (Basic)	2	1	1	0	0
Shares Outstanding (Diluted)	2	1	1	0	0
Shares Change	158.35%	14.02%	93.68%	13.08%	5.45%
EPS (Basic)	-5.13	-17.97	-12.52	-30.40	-9.00
EPS (Diluted)	-5.13	-17.97	-12.52	-30.40	-9.00
Free Cash Flow	-5.2	-6.62	-6.48	-4.86	1.31
Free Cash Flow Per Share	-3.32	-10.91	-12.20	-17.72	5.38
Gross Margin	35.96%	-3.48%	96.51%	91.44%	90.56%
Operating Margin	-224.04%	-1292.45%	-125.39%	-531.67%	-120.80%
Profit Margin	-266.00%	-1324.81%	-159.97%	-804.73%	-146.43%
Free Cash Flow Margin	-172.15%	-804.68%	-155.87%	-468.92%	88.21%
EBITDA	-6.88	-10.75	-5.22	-5.48	-1.75
EBITDA Margin	-227.77%	-1307.83%	-125.45%	-527.94%	-118.50%
Depreciation & Amortization	0.2	0.08	0.17	0.03	0.03
EBIT	-7.08	-10.83	-5.38	-5.51	-1.78
EBIT Margin	-234.42%	-1317.23%	-129.44%	-531.27%	-120.22%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).